Cargando…

ELR510444 Inhibits Tumor Growth and Angiogenesis by Abrogating HIF Activity and Disrupting Microtubules in Renal Cell Carcinoma

BACKGROUND: Hypoxia-inducible factor (HIF) is an attractive therapeutic target for renal cell carcinoma (RCC) as its high expression due to the loss of von Hippel-Lindau (VHL) promotes RCC progression. Considering this, we hypothesized that ELR510444, a novel orally available small molecule inhibito...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carew, Jennifer S., Esquivel, Juan A., Espitia, Claudia M., Schultes, Christoph M., Mülbaier, Marcel, Lewis, Joe D., Janssen, Bernd, Giles, Francis J., Nawrocki, Steffan T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266297/ https://www.ncbi.nlm.nih.gov/pubmed/22295124 http://dx.doi.org/10.1371/journal.pone.0031120

Ejemplares similares

Oncolytic reovirus inhibits angiogenesis through induction of CXCL10/IP-10 and abrogation of HIF activity in soft tissue sarcomas
por: Carew, Jennifer S., et al.
Publicado: (2017)

Structural insights into targeting of the colchicine binding site by ELR510444 and parbendazole to achieve rational drug design
por: Lei, Jia-Hong, et al.
Publicado: (2021)

Microparticles stimulate angiogenesis by inducing ELR(+) CXC-chemokines in synovial fibroblasts
por: Reich, Nicole, et al.
Publicado: (2011)

Moving beyond hydroxychloroquine: the novel lysosomal autophagy inhibitor ROC-325 shows significant potential in preclinical studies
por: Jones, Trace M., et al.
Publicado: (2019)

Targeting JAK/STAT Signaling Antagonizes Resistance to Oncolytic Reovirus Therapy Driven by Prior Infection with HTLV-1 in Models of T-Cell Lymphoma
por: Islam, Shariful, et al.
Publicado: (2021)

Heightened JNK Activation and Reduced XIAP Levels Promote TRAIL and Sunitinib-Mediated Apoptosis in Colon Cancer Models
por: Mahalingam, Devalingam, et al.
Publicado: (2019)

Targeted CUL4A inhibition synergizes with cisplatin to yield long-term survival in models of head and neck squamous cell carcinoma through a DDB2-mediated mechanism
por: Jones, Trace M., et al.
Publicado: (2022)

Targeting autophagy: a novel anticancer strategy with therapeutic implications for imatinib resistance
por: Carew, Jennifer S, et al.
Publicado: (2008)

PGF(2α) facilitates pathological retinal angiogenesis by modulating endothelial FOS‐driven ELR (+) CXC chemokine expression
por: Zhao, Yan, et al.
Publicado: (2022)

ELR+ CXC chemokine expression in benign and malignant colorectal conditions
por: Rubie, Claudia, et al.
Publicado: (2008)

Overexpression of Enterococcus faecalis elr operon protects from phagocytosis
por: Cortes-Perez, Naima G., et al.
Publicado: (2015)

Silk-ELR co-recombinamer covered stents obtained by electrospinning
por: Putzu, M, et al.
Publicado: (2019)

Genome editing abrogates angiogenesis in vivo
por: Huang, Xionggao, et al.
Publicado: (2017)

Junctional adhesion molecule-A is overexpressed in advanced multiple myeloma and determines response to oncolytic reovirus
por: Kelly, Kevin R., et al.
Publicado: (2015)

Targeting NEDDylation is a Novel Strategy to Attenuate Cisplatin-induced Nephrotoxicity
por: Jones, Trace M., et al.
Publicado: (2023)

Autophagy: New Insights into Its Roles in Cancer Progression and Drug Resistance
por: Nawrocki, Steffan T., et al.
Publicado: (2020)

A Protective Role for ELR+ Chemokines during Acute Viral Encephalomyelitis
por: Hosking, Martin P., et al.
Publicado: (2009)

Autophagy as a target for cancer therapy: new developments
por: Carew, Jennifer S, et al.
Publicado: (2012)

Therapeutic Targeting of Autophagy for Renal Cell Carcinoma Therapy
por: Jones, Trace M., et al.
Publicado: (2020)

Challenges of ELR Implementation: Moving Toward Semantic Understanding through Vocabulary Validation
por: Golson, Daniel B., et al.
Publicado: (2014)

ELR positive CXCL chemokines are highly expressed in an animal model of ulcerative colitis
por: Boshagh, Mohammad Amin, et al.
Publicado: (2019)

Discovery and characterization of a neutralizing pan-ELR+CXC chemokine monoclonal antibody
por: Boyles, Jeffrey S., et al.
Publicado: (2020)

CXC ELR-Positive Chemokines as Diagnostic and Prognostic Markers for Breast Cancer Patients
por: Motyka, Joanna, et al.
Publicado: (2023)

Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapy
por: Kelly, Kevin R., et al.
Publicado: (2017)

Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinoma
por: Mahalingam, D, et al.
Publicado: (2011)

Epigenetics Underpinning the Regulation of the CXC (ELR(+)) Chemokines in Non-Small Cell Lung Cancer
por: Baird, Anne-Marie, et al.
Publicado: (2011)

Exploration of the role of the virulence factor ElrA during Enterococcus faecalis cell infection
por: Nunez, Natalia, et al.
Publicado: (2018)

Microtubule disruption targets HIF-1α mRNA to cytoplasmic P-bodies for translational repression
por: Carbonaro, Marisa, et al.
Publicado: (2011)

ABCG2 Overexpression Contributes to Pevonedistat Resistance
por: Kathawala, Rishil J., et al.
Publicado: (2020)

Targeting NEDDylation as a Novel Approach to Improve the Treatment of Head and Neck Cancer
por: Jones, Trace M., et al.
Publicado: (2021)

Stable knockdown of CREB, HIF-1 and HIF-2 by replication-competent retroviruses abrogates the responses to hypoxia in hepatocellular carcinoma
por: Shneor, D, et al.
Publicado: (2017)

The coordinated action of G-CSF and ELR + CXC chemokines in neutrophil mobilization during acute inflammation
por: Wengner, Antje M., et al.
Publicado: (2008)

The novel Aurora A kinase inhibitor MLN8237 is active in resistant chronic myeloid leukaemia and significantly increases the efficacy of nilotinib
por: Kelly, Kevin R, et al.
Publicado: (2011)

The Th17–ELR(+) CXC chemokine pathway is essential for the development of central nervous system autoimmune disease
por: Carlson, Thaddeus, et al.
Publicado: (2008)

ElrA binding to the 3′UTR of cyclin E1 mRNA requires polyadenylation elements
por: Slevin, Michael K., et al.
Publicado: (2007)

ELR(+) chemokine signaling in host defense and disease in a viral model of central nervous system disease
por: Hosking, Martin P., et al.
Publicado: (2014)

Mice transgenic for equine cyclin T1 and ELR1 are susceptible to equine infectious anemia virus infection
por: Du, Cheng, et al.
Publicado: (2015)

Targeting of the ELR+CXCL/CXCR1/2 Pathway Is a Relevant Strategy for the Treatment of Paediatric Medulloblastomas
por: Penco-Campillo, Manon, et al.
Publicado: (2022)

HAF mediates the evasive resistance of anti-angiogenesis TKI through disrupting HIF-1α and HIF-2α balance in renal cell carcinoma
por: Lai, Xiang-Me, et al.
Publicado: (2017)

Oncolytic Viruses for Multiple Myeloma Therapy
por: Calton, Christine M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_inafj98qa4b03es95h67a3eu1h